Show simple item record

Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma

dc.contributor.authorBozkurt, Mehmet Abdussamet
dc.contributor.authorAfsar, Cigdem Usul
dc.contributor.authorSerilmez, Murat
dc.contributor.authorKarabulut, Senem
dc.contributor.authorKarabulut, Mehmet
dc.contributor.authorAlis, Halil
dc.contributor.authorTas, Faruk
dc.contributor.authorAydogan, Fatma
dc.date.accessioned2021-03-03T08:00:08Z
dc.date.available2021-03-03T08:00:08Z
dc.identifier.citationKarabulut S., Afsar C. U. , Karabulut M., Alis H., Bozkurt M. A. , Aydogan F., Serilmez M., Tas F., "Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma", BBA CLINICAL, cilt.6, ss.138-142, 2016
dc.identifier.otherav_151cd769-be63-4444-8d50-5e0dedda4073
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/19574
dc.identifier.urihttps://doi.org/10.1016/j.bbacli.2016.10.002
dc.description.abstractBackground: Omentin is related with metabolic syndrome and obesity. Pancreatic adenocarcinoma (PA) is a lethal and obesity-linked malignancy. This study was conducted to investigate the serum levels of omentin in patients with PA and the relationship with tumor progression and known prognostic parameters.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectTemel Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleClinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma
dc.typeMakale
dc.relation.journalBBA CLINICAL
dc.contributor.departmentIstanbul Training & Research Hospital , ,
dc.identifier.volume6
dc.identifier.startpage138
dc.identifier.endpage142
dc.contributor.firstauthorID237410


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record